CUHK and HKSTP open a new ATP GMP Centre to fast-track the cell and gene therapy (CGT) manufacturing industry in Hong Kong and the GBA

CUHK and HKSTP formally open the Advanced Therapy Products (ATP) Good Manufacturing Practice (GMP) Centre located at the Hong Kong Institute of Biotechnology Limited (HKIB).

State-of-the-art facility accelerates clinical trials to commercialisation with international PIC/S GMP-compliant manufacturing processes :

中大先進治療產品良好生產規範中心 為癌症病人重燃希望

改造一個小小的細胞,可讓癌症治療向前邁進了一大步。近年細胞和基因治療在醫治和預防疾病方面取得革命性進展,然而這些治療方案在香港的價格十分昂貴,令病人難以負擔,而且大多數是在海外生產,過程非常耗時和充滿不確定,不少病人等不及治療就已離世。

中大新中心研細胞基因治療產品 改造程序落戶本地 省時減成本

(左起) 香港中文大學副校長陳偉儀教授,香港科技園公司行政總裁黃克強先生,香港中文大學校長段崇智教授,香港生物科技研究院院長江宜蓁醫生,中大醫學院兒科學系教授李志光教授

創科發展日漸成熟,癌症治療亦邁向科技化。中文大學成立「先進治療產品良好生產規範中心」下月正式啟用,是本港首個製造細胞及基因治療產品的科研機構,以基因改造細胞技術治療癌症、骨骼衰弱等,以往依賴海外完成的基因改造程序,有望改為本地研發,節省時間及成本;中心將與本地兩所醫院合作臨牀治療及研究。校長段崇智指,中心將積極推動生物醫學科技的研究,並歡迎其他院校加入。

GMP Facility In Hong Kong To Accelerate Life-Saving Treatments

CUHK has entered into a new partnership with the Hong Kong Science and Technology Parks Corporation (HKSTP) to build a world-class Good Manufacturing Practice (GMP) facility in Hong Kong to accelerate the development of life-saving cancer therapies, regenerative medicine and related biomedical technologies.

CUHK And HKSTP Partner To Establish A World-Class GMP Facility To Drive Cell Therapy Development In Hong Kong

The Chinese University of Hong Kong (CUHK) and Hong Kong Science and Technology Parks Corporation (HKSTP), announce their partnership to build a world-class Good Manufacturing Practice (GMP) facility in Hong Kong to accelerate the development of life-saving cancer therapies, regenerative medicine, and related biomedical technologies.

CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

The Chinese University of Hong Kong (CUHK) will commence clinical trials of Chimeric antigen receptor-T cell (CAR-T cell) therapy, with the first phase targeting patients with haematological malignancy. The plan is to increase the survival rate and prolong overall survival for these patients.